DLG2 Mutations in the Etiology of Pubertal Delay and Idiopathic Hypogonadotropic Hypogonadism.
DLG2
Idiopathic hypogonadotropic hypogonadism
Oligogenic inheritance
Journal
Hormone research in paediatrics
ISSN: 1663-2826
Titre abrégé: Horm Res Paediatr
Pays: Switzerland
ID NLM: 101525157
Informations de publication
Date de publication:
2021
2021
Historique:
received:
29
06
2021
accepted:
22
10
2021
pubmed:
26
10
2021
medline:
5
4
2022
entrez:
25
10
2021
Statut:
ppublish
Résumé
Idiopathic hypogonadotropic hypogonadism (IHH) is caused by dysfunction of the hypothalamic-pituitary-gonadal axis. DLG2 was recently implicated as a gene associated with delayed puberty and which may also contribute to IHH. The confirmation of the candidate puberty genes in independent IHH cohorts has become crucial due to the lack of proper genotype-phenotype segregations in reported pedigrees. Therefore, we aimed to screen DLG2 in patient variants in a large cohort of IHH patients. The present study included a total of 336 IHH patients from 290 independent families. The coding and flanking regions of DLG2 were screened for potentially important variants in the WES data. Candidate variants were evaluated in the -gnomAD and GME databases according to their allele frequencies, and only those with a frequency <0.0001 were considered rare. Detected variants were classified according to the ACMG/AMP criteria. We found 1 homozygous and 2 heterozygous missense variants in 3 independent pedigrees. Identified variants were found extremely rare or not reported in gnomAD. Two variants were categorized as "uncertain significance," and the other one was "likely pathogenic" according to the ACMG criteria. All patients were normosmic, and in 2 of the 3 families, there were no causal variants in other IHH-related genes. We detected 3 rare sequencing variants in DLG2 in 5 patients with IHH or delayed puberty in a large IHH cohort. Our results support the contention that the DLG2 mutations are associated with IHH in human puberty.
Identifiants
pubmed: 34695822
pii: 000520409
doi: 10.1159/000520409
doi:
Substances chimiques
Tumor Suppressor Proteins
0
DLG2 protein, human
EC 2.7.4.8
Guanylate Kinases
EC 2.7.4.8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
364-368Informations de copyright
© 2021 S. Karger AG, Basel.